A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies

Clinical trial NCT01080664 · TERMINATED

Trial details

NCT number: NCT01080664
Sponsor: EMD Serono
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Haematological Malignancies

Start date: 2006-12-01
Primary completion: 2010-03-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.